MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
MetLife, Inc.NYSE: MET
Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026
Weighted avg shares (diluted) declines year over year
Q2 FY2026 weighted avg shares (diluted) of 655.7M shares fell 2.9% year over year, ahead of the -4.3% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -6.3% a year.
Context
- Weighted avg shares (diluted) increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -2.9% holds above the trailing-twelve-month pace of -4.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 664.96M USD
- Year-over-year change
- -6.5%
- 4-year CAGR
- -6.5%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 664.96M | -6.5% |
| FY2024 | 2024-12-31 | 711.1M | -6.7% |
| FY2023 | 2023-12-31 | 762.43M | -5.7% |
| FY2022 | 2022-12-31 | 808.9M | -7.0% |
| FY2021 | 2021-12-31 | 869.4M | — |
Weighted Avg Shares (Diluted) vs competitors
How MET compares with its peers on the latest reported figures
- MET's LTM Jun 2026 weighted avg shares (diluted) of 661.36M shares is the 2nd highest of the 11 companies compared; the peer median is 131.38M shares.
- Its year-over-year change of -4.3% is the 6th highest of 11, against a peer median of -4.1%.
- Over three fiscal years its annual growth of -6.3% compares with a peer median of -5.0%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | 1.7B | -3.1% | -3.7% | |
| LTM Jun 2026 | 661.36M | -4.3% | -6.3% | |
| LTM Jun 2026 | 521.1M | -5.7% | -5.9% | |
| LTM Jun 2026 | 344.24M | -3.5% | -2.0% | |
| LTM Jun 2026 | 195.83M | +11.5% | +2.5% | |
| LTM Jun 2026 | 165.76M | -8.1% | -5.1% | |
| LTM Jun 2026 | 97M | -1.8% | -4.2% | |
| LTM Jun 2026 | 96.23M | -7.8% | -6.0% | |
| LTM Sep 2026 | 79.67M | -4.6% | -6.5% | |
| LTM Sep 2026 | 57.8M | -1.5% | -8.1% | |
| LTM Sep 2026 | 23.75M | -28.5% | -5.0% | |
| Peer median (excluding MET) | 131.38M | -4.1% | -5.0% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 63.37B | 67.97B | 67.71B | 69.94B | 77.08B |
| Cost of Revenue | 46.53B | 49.03B | 50.42B | 50.94B | 49.06B |
| Gross Profit | 16.84B | 18.94B | 17.29B | 19B | 28.02B |
| Gross Margin | 26.6% | 27.9% | 25.5% | 27.2% | 36.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.76B | 5.86B | 6.18B | 5.99B | 0 |
| Operating Expenses | 8.32B | 12.57B | 15.13B | 13.38B | 23.36B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| EBITDA | 10.13B | 7.98B | 3.93B | 7.37B | 6.48B |
| EBITDA Margin | 16.0% | 11.7% | 5.8% | 10.5% | 8.4% |
| Operating Income | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Operating Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 920M | 938M | 1.05B | 1.04B | 1.06B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Pre-Tax Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Income Tax Expense | 1.64B | 1.06B | 560M | 1.18B | 1.26B |
| Net Income | 6.86B | 5.28B | 1.58B | 4.43B | 3.38B |
| Net Margin | 10.8% | 7.8% | 2.3% | 6.3% | 4.4% |
| EPS (Basic) | 7.70 | 6.35 | 1.82 | 5.98 | 4.80 |
| EPS (Diluted) | 7.65 | 6.30 | 1.81 | 5.94 | 4.80 |
| Weighted Avg Shares | 825.54M | 779.1M | 762.43M | 689.21M | 664.96M |
| Weighted Avg Shares (Diluted) | 869.4M | 808.9M | 762.43M | 711.1M | 664.96M |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.